These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 30963)

  • 1. [Data from the study of effort blood pressure profile in hypertensive subjects, before and after treatment].
    Debru JL; Doyon B; Morin B; Perdrix A; Mallion JM
    Nouv Presse Med; 1978 Sep; 7(31):2777-82. PubMed ID: 30963
    [No Abstract]   [Full Text] [Related]  

  • 2. [Utilization of pindolol in arterial hypertension. Study during rest and during effort].
    Tassy J; Jouve A
    Nouv Presse Med; 1978 Sep; 7(31):2783-4. PubMed ID: 30964
    [No Abstract]   [Full Text] [Related]  

  • 3. [The combination of methyldopa with pindolol in the treatment of hypertension (author's transl)].
    Szám I; Pálossy B
    MMW Munch Med Wochenschr; 1978 Dec; 120(51-52):1719-22. PubMed ID: 105251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the combination of Pindolol and clopamide in systemic arterial hypertension. A multicenter study].
    Zilenovski AM; Freire CA
    Arq Bras Cardiol; 1981 Sep; 37(3):219-24. PubMed ID: 7052028
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of essential hypertension with pindolol and clopamide: problems arising from a combined beta blocker and diuretic therapy.
    Rosenfeld JB; Traub YM; Cohen L
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):786-97. PubMed ID: 4217245
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal).
    Bjerle P; Jacobsson KA; Agert G
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607
    [No Abstract]   [Full Text] [Related]  

  • 7. [Potassium metabolism in combined administration of pindolol and clopamide in long-term treatment of hypertension (author's transl)].
    Faupel RP; Gotzen R
    Dtsch Med Wochenschr; 1978 Oct; 103(41):1602-5. PubMed ID: 100301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of long-term treatment with a beta-receptor blocker, pindolol, combined with a diuretic agent, clopamide, on exercise performance in hypertension.
    Reiterer W
    Curr Med Res Opin; 1980; 6(8):552-8. PubMed ID: 7389386
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy with hydrazinopyridazine, a new antihypertensive vasodilatory agent, in combination with beta-receptor blocking substances.
    Kirch W; von Gizycki C
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):233-5. PubMed ID: 6104636
    [No Abstract]   [Full Text] [Related]  

  • 11. [Should elderly hypertensive patients be treated with a beta-blocker-diuretic combination?].
    Böhmer F
    Z Gerontol; 1984; 17(2):89-92. PubMed ID: 6730636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavior of the blood pressure curve during the ergometric stress test, in treated and non-treated hypertensive patients].
    Carrasco RM; da Rocha MM; Luna RL
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():24-32. PubMed ID: 7325860
    [No Abstract]   [Full Text] [Related]  

  • 13. Methyldopa (Aldomet) in combination with timolol (Blocadren) in the treatment of hypertension.
    Seedat YK
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):10-8. PubMed ID: 8279
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-adrenergic blocking agents in the treatment of pregnancy-induced hypertension.
    Paran E; Holzberg G; Mazor M; Zmora E; Insler V
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):119-23. PubMed ID: 7757311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative trial of fixed ratio beta-adrenoceptor blocker and diuretic combination products in moderate hypertension.
    Watt SJ; Lee MR
    Pharmatherapeutica; 1980; 2(7):487-93. PubMed ID: 6111083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hypertension with a combination of prindolol and clopamide (author's transl)].
    Gábor G; Jávor T; Szám I; Török E
    MMW Munch Med Wochenschr; 1975 Nov; 117(46):1853-6. PubMed ID: 811982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
    Spieker C; Vetter W; Zidek W; Vetter H
    Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study].
    Werning C; Hammerschmidt D; Kaiser Hj
    Med Welt; 1978 Oct; 29(40):1570-5. PubMed ID: 703579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antihypertensive properties of a beta blocking agent, pindolol].
    Safar M; Weiss Y; Sobel A; Lagrue G; Milliez P
    Nouv Presse Med; 1973 Nov; 2(40):2685-8. PubMed ID: 4586561
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antihypertensive efficacy and tolerance of bopindolol (LT 31-200) in hypertensive patients].
    Honorato J; Galende I; Catalán M; Azanza JR
    Rev Med Univ Navarra; 1990; 34(2):90-4. PubMed ID: 1983366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.